Creation of a Vaccine Research InstituteWorking with universities, institutes, and schools to support vaccine research in India
The global human population has been under attack for millennium. These attacks have come from bacteria, viruses, fungi, protozoa, and helminths. There are estimated to be 1,400 known species of human pathogens. As we see today with the global ravages of the SARS-CoV-2 virus these attacks can have devastating consequences.
With this in mind, the Mehta Family Foundation has embarked on program to reduce the impact of human pathogens. In particular, the Foundation intends to focus on viruses and the development of protective vaccines. Furthermore, targeting India as the initial region for research because of the low development of research in the area.
The Foundation recognized there are specific viruses common to India which do not have any research investments in India. Many of these such as enteric fever, dengue, and chikungunya are common. Due to the nature and location of the viruses causing them, the development of vaccines been slow. As seen in other fields of study, India has the talent and capacity to expand the field of vaccine research.
The intent is to build one or more vaccine research institutes in India which will be one of a kind. Not only will these institutes be charged with creating new vaccines, they will be designed to graduate new masters and doctoral researchers. This process will generate talent to expand research into viral diseases not only in India but other regions around the World.
The Foundation is at stage one of the program. Proposals have been received from a number of well positioned institutes and universities anxious to build a vaccine research center. The Foundation along with advisors is in the process of reviewing these proposals.
The Foundation is hopeful this project will not only bring new vaccines to market, but also expand India’s human capital in a critical field.